A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis

References

• Fourie ED, Morrison JG. Rheumatoid arthritic syndrome after chikungunya fever. S Afr Med J 1979; 56:130-2; PMID:494034
   PubMed Web of Science ®Google Scholar
• Brighton SW, Prozesky OW, de la Harpe AL. Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J 1983; 63:313-5; PMID:6298956
   PubMed Web of Science ®Google Scholar
• Kee AC, Yang S, Tambyah P. Atypical chikungunya virus infections in immunocompromised patients. Emerg Infect Dis 2010; 16:1038-40; PMID:20507772; http://dx.doi.org/10.3201/eid1606.091115
   PubMed Web of Science ®Google Scholar
• Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 2010; 184:5914-27; PMID:20404278; http://dx.doi.org/10.4049/jimmunol.0900255
   PubMed Web of Science ®Google Scholar
• Pellot AS, Alessandri JL, Robin S, Samperiz S, Attali T, Brayer C, Pasquet M, Jaffar-Bandjee MC, Benhamou LS, Tiran-Rajaofera I, et al. Severe forms of chikungunya virus infection in a pediatric intensive care unit on Reunion Island. Med Trop (Mars) 2012; 72 Spec No:88-93; PMID:22693937
   PubMedGoogle Scholar
• Robin S, Ramful D, Le Seach F, Jaffar-Bandjee MC, Rigou G, Alessandri JL. Neurologic manifestations of pediatric chikungunya infection. J Child Neurol 2008; 23:1028-35; PMID:18287573; http://dx.doi.org/10.1177/0883073808314151
   PubMed Web of Science ®Google Scholar
• Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006; 3:e263; PMID:16700631; http://dx.doi.org/10.1371/journal.pmed.0030263
   PubMed Web of Science ®Google Scholar
• Njenga MK, Nderitu L, Ledermann JP, Ndirangu A, Logue CH, Kelly CHL, Sang R, Sergon K, Breiman R, Powers AM. Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa. J Gen Virol 2008; 89:2754-60; PMID:18931072; http://dx.doi.org/10.1099/vir.0.2008/005413-0
   PubMed Web of Science ®Google Scholar
• Ravi V. Re-emergence of chikungunya virus in India. Indian J Med Microbiol 2006; 24:83-4; PMID:16687855; http://dx.doi.org/10.4103/0255-0857.25175
   PubMedGoogle Scholar
• Pulmanausahakul R, Roytrakul S, Auewarakul P, Smith DR. Chikungunya in Southeast Asia: understanding the emergence and finding solutions. Int J Infect Dis 2011; 15:e671-6; PMID:21775183; http://dx.doi.org/10.1016/j.ijid.2011.06.002
   PubMed Web of Science ®Google Scholar
• Viennet E, Knope K, Faddy HM, Williams CR, Harley D. Assessing the threat of chikungunya virus emergence in Australia. Commun Dis Intell Q Rep 2013; 37:E136-43; PMID:24168087
   PubMedGoogle Scholar
• Dogan AD, Bunes K, Skarphédinsson S. The tropical disease Chikungunya fever has come to Europe. Ugeskr Laeger 2013; 175:1716-9; PMID:23763933
   PubMedGoogle Scholar
• Powers AM. Risks to the Americas associated with the continued expansion of chikungunya virus. J Gen Virol 2015; 96:1-5; PMID:25239764; http://dx.doi.org/10.1099/vir.0.070136-0
   PubMed Web of Science ®Google Scholar
• Van Bortel W, Dorleans F, Rosine J, Blateau A, Rousset D, Matheus S, Leparc-Goffart I, Flusin O, Prat C, Cesaire R, et al. Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill 2014; 19:pii=20759
   Google Scholar
• Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 1994; 58:491-562; PMID:7968923
   PubMedGoogle Scholar
• Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 2010; 468:709-12; PMID:21124458; http://dx.doi.org/10.1038/nature09555
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Zhang W, Gabler S, Chipman PR, Strauss EG, Strauss JH, Baker TS, Kuhn RJ, Rossmann MG. Mapping the structure and function of the E1 and E2 glycoproteins in alphaviruses. Structure 2006; 14:63-73; PMID:16407066; http://dx.doi.org/10.1016/j.str.2005.07.025
   PubMed Web of Science ®Google Scholar
• Smith TJ, Cheng RH, Olson NH, Peterson P, Chase E, Kuhn RJ, Baker TS. Putative receptor binding sites on alphaviruses as visualized by cryoelectron microscopy. PNAS 1995; 92:10648-52; PMID:7479858; http://dx.doi.org/10.1073/pnas.92.23.10648
   PubMed Web of Science ®Google Scholar
• Li L, Jose J, Xiang Y, Kuhn RJ, Rossmann MG. Structural changes of envelope proteins during alphavirus fusion. Nature 2010; 468:705-8; PMID:21124457; http://dx.doi.org/10.1038/nature09546
   PubMed Web of Science ®Google Scholar
• Mohan A. Chikungunya fever: clinical manifestations & management. Indian J Med Res 2006; 124:471-4; PMID:17213512
   PubMed Web of Science ®Google Scholar
• Kaur P, Chu JJ. Chikungunya virus: an update on antiviral development and challenges. Drug Discov Today 2013; 18:969-83; PMID:23684571; http://dx.doi.org/10.1016/j.drudis.2013.05.002
   PubMed Web of Science ®Google Scholar
• Gerardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, Lenglet Y, Touret Y, Bouveret A, Grivard P, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Reunion. PLoS Med 2008; 5:e60; PMID:18351797; http://dx.doi.org/10.1371/journal.pmed.0050060
   PubMed Web of Science ®Google Scholar
• Edelman R, Tacket CO, Wasserman SS, Bodison SA, Perry JG, Mangiafico JA. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 2000; 62:681-5; PMID:11304054
   PubMed Web of Science ®Google Scholar
• Hallengard D, Kakoulidou M, Lulla A, Kummerer BM, Johansson DX, Mutso M, Lulla V, Fazakerley JK, Roques P, Le Grand R, et al. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice. J Virol 2014; 88:2858-66; PMID:24371047; http://dx.doi.org/10.1128/JVI.03453-13
   PubMed Web of Science ®Google Scholar
• Tretyakova I, Hearn J, Wang E, Weaver S, Pushko P. DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice. J Infect Dis 2014; 209:1882-90; PMID:24585894; http://dx.doi.org/10.1093/infdis/jiu114
   PubMed Web of Science ®Google Scholar
• Khan M, Dhanwani R, Rao PV, Parida M. Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in mice. Virus Res 2012; 167:236-46; PMID:22610133; http://dx.doi.org/10.1016/j.virusres.2012.05.004
   PubMed Web of Science ®Google Scholar
• Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, Lewis MG, Higgs S, Rossmann MG, Rao S, et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 2010; 16:334-8; PMID:20111039; http://dx.doi.org/10.1038/nm.2105
   PubMed Web of Science ®Google Scholar
• Couderc T, Khandoudi N, Grandadam M, Visse C, Gangneux N, Bagot S, Prost JF, Lecuit M. Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis 2009; 200:516-23; PMID:19572805; http://dx.doi.org/10.1086/600381
   PubMed Web of Science ®Google Scholar
• Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, Lee I. Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus. PLoS Pathog 2013; 9:e1003312; PMID:23637602; http://dx.doi.org/10.1371/journal.ppat.1003312
   PubMed Web of Science ®Google Scholar
• Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, Bertin-Maghit S, Ng LF, Abastado JP, Despres P, et al. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. J Immunol 2011; 186:3258-64; PMID:21278338; http://dx.doi.org/10.4049/jimmunol.1003139
   PubMed Web of Science ®Google Scholar
• Goh LY, Hobson-Peters J, Prow NA, Gardner J, Bielefeldt-Ohmann H, Pyke AT, Suhrbier A, Hall RA. Neutralizing monoclonal antibodies to the E2 protein of chikungunya virus protects against disease in a mouse model. Clin Immunol 2013; 149:487-97; PMID:24239837; http://dx.doi.org/10.1016/j.clim.2013.10.004
   PubMed Web of Science ®Google Scholar
• Masrinoul P, Puiprom O, Tanaka A, Kuwahara M, Chaichana P, Ikuta K, Ramasoota P, Okabayashi T. Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release. Virol J 2014; 464-465:111-7; PMID:24927852
   PubMed Web of Science ®Google Scholar
• Selvarajah S, Sexton NR, Kahle KM, Fong RH, Mattia KA, Gardner J, Lu K, Liss NM, Salvador B, Tucker DF, et al. A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease. PLoS Negl Trop Dis 2013; 7:e2423; PMID:24069479; http://dx.doi.org/10.1371/journal.pntd.0002423
   PubMed Web of Science ®Google Scholar
• Fong RH, Banik SS, Mattia K, Barnes T, Tucker D, Liss N, Lu K, Selvarajah S, Srinivasan S, Mabila M, et al. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy. J Virol 2014; 88:14364-79; PMID:25275138; http://dx.doi.org/10.1128/JVI.01943-14
   PubMed Web of Science ®Google Scholar
• Kam YW, Lum FM, Teo TH, Lee WW, Simarmata D, Harjanto S, Chua CL, Chan YF, Wee JK, Chow A, et al. Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO Mol Med 2012; 4:330-43; PMID:22389221; http://dx.doi.org/10.1002/emmm.201200213
   PubMed Web of Science ®Google Scholar
• Lum FM, Teo TH, Lee WW, Kam YW, Renia L, Ng LF. An essential role of antibodies in the control of Chikungunya virus infection. J Immunol 2013; 190:6295-302; PMID:23670192; http://dx.doi.org/10.4049/jimmunol.1300304
   PubMed Web of Science ®Google Scholar
• Kam YW, Lee WW, Simarmata D, Harjanto S, Teng TS, Tolou H, Chow A, Lin RT, Leo YS, Renia L, et al. Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development. J Virol 2012; 86:13005-15; PMID:23015702; http://dx.doi.org/10.1128/JVI.01780-12
   PubMed Web of Science ®Google Scholar
• Cavallo L, Kleinjung J, Fraternali F. POPS: A fast algorithm for solvent accessible surface areas at atomic and residue level. Nucleic Acids Res 2003; 31:3364-6; PMID:12824328; http://dx.doi.org/10.1093/nar/gkg601
   PubMed Web of Science ®Google Scholar
• Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, et al. A mouse model for chikungunya: Young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008; 4:e29; PMID:18282093; http://dx.doi.org/10.1371/journal.ppat.0040029
   PubMed Web of Science ®Google Scholar
• Dhanwani R, Khan M, Lomash V, Rao P, Ly H, Parida M. Characterization of Chikungunya Virus Induced Host Response in a Mouse Model of Viral Myositis. PLoS One 2014; 9:e92813; PMID:24667237; http://dx.doi.org/10.1371/journal.pone.0092813
   PubMedGoogle Scholar
• Klasse PJ, Sattentau QJ. Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J Gen Virol 2002; 83:2091-108; PMID:12185262
   PubMed Web of Science ®Google Scholar
• Feinstein A, Munn EA, Richardson NE. The three-dimensional conformation of M and A globulin molecules. Ann N Y Acad Sci 1971; 190:104-21; PMID:5290007; http://dx.doi.org/10.1111/j.1749-6632.1971.tb13526.x
   PubMed Web of Science ®Google Scholar
• Strauss EG, Stec DS, Schmaljohn AL, Strauss JH. Identification of antigenically important domains in the glycoproteins of Sindbis virus by analysis of antibody escape variants. J Virol 1991; 65:4654-64; PMID:1714515
   PubMed Web of Science ®Google Scholar
• Vrati S, Fernon CA, Dalgarno L, Weir RC. Location of a major antigenic site involved in Ross River virus neutralization. Virol J 1988; 162:346-53; http://dx.doi.org/10.1016/0042-6822(88)90474-6
   Web of Science ®Google Scholar
• Agapov EV, Razumov IA, Frolov IV, Kolykhalov AA, Netesov SV, Loktev VB. Localization of four antigenic sites involved in Venezuelan equine encephalomyelitis virus protection. Arch Virol 1994; 139:173-81; PMID:7529989; http://dx.doi.org/10.1007/BF01309462
   PubMed Web of Science ®Google Scholar
• Heil M, Albee A, Strauss J, Kuhn R. An amino acid substitution in the coding region of the E2 glycoprotein adapts Ross River virus to utilize heparan sulfate as an attachment moiety. J Virol 2001; 75:6303-9; PMID:11413296; http://dx.doi.org/10.1128/JVI.75.14.6303-6309.2001
   PubMed Web of Science ®Google Scholar
• Tsetsarkin K, McGee C, Volk S, Vanlandingham D, Weaver S, Higgs S. Epistatic Roles of E2 Glycoprotein Mutations in Adaption of Chikungunya Virus to Aedes Albopictus and Ae. Aegypti Mosquitoes. PLoS One 2009; 4:e6835; PMID:19718263; http://dx.doi.org/10.1371/journal.pone.0006835
   PubMed Web of Science ®Google Scholar
• Tsetsarkin K, Vanlandingham D, McGee C, Higgs S. A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential. PLoS Pathog 2007; 3:e201; PMID:18069894; http://dx.doi.org/10.1371/journal.ppat.0030201
   PubMed Web of Science ®Google Scholar
• Powers AM, Logue CH. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 2007; 88:2363-77; PMID:17698645; http://dx.doi.org/10.1099/vir.0.82858-0
   PubMed Web of Science ®Google Scholar
• Ochsenbein AF, Zinkernagel RM. Natural antibodies and complement link innate and acquired immunity. Immunol Today 2000; 21:624-30; PMID:11114423; http://dx.doi.org/10.1016/S0167-5699(00)01754-0
   PubMedGoogle Scholar
• Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum 2008; 58:2921-2; PMID:18759351; http://dx.doi.org/10.1002/art.23753
   PubMed Web of Science ®Google Scholar
• Malvy D, Ezzedine K, Mamani-Matsuda M, Autran B, Tolou H, Receveur MC, Pistone T, Rambert J, Moynet D, Mossalayi D. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis 2009; 9:200; PMID:20003320; http://dx.doi.org/10.1186/1471-2334-9-200
   PubMed Web of Science ®Google Scholar
• Calisher CH, el-Kafrawi AO, Al-Deen Mahmud MI, Travassos da Rosa AP, Bartz CR, Brummer-Korvenkontio M, Haksohusodo S, Suharyono W. Complex-specific immunoglobulin M antibody patterns in humans infected with alphaviruses. J Clin Microbiol 1986; 23:155-9; PMID:3009526
   PubMed Web of Science ®Google Scholar
• Borgherini G, Poubeau P, Staikowsky F, Lory M, Le Moullec N, Becquart JP, Wengling C, Michault A, Paganin F. Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 2007; 44:1401-7; PMID:17479933; http://dx.doi.org/10.1086/517537
   PubMed Web of Science ®Google Scholar
• Fric J, Bertin-Maghit S, Wang C-I, Nardin A, Warter L. Use of Human Monoclonal Antibodies to Treat Chikungunya Virus Infection. J Infect Dis 2013; 207:319-22; PMID:23125446; http://dx.doi.org/10.1093/infdis/jis674
   PubMed Web of Science ®Google Scholar
• Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol 2011; 178:32-40; PMID:21224040; http://dx.doi.org/10.1016/j.ajpath.2010.11.018
   PubMed Web of Science ®Google Scholar
• Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, Schroder WA, Higgs S, Suhrbier A. Chikungunya virus arthritis in adult wild-type mice. J Virol 2010; 84:8021-32; PMID:20519386; http://dx.doi.org/10.1128/JVI.02603-09
   PubMed Web of Science ®Google Scholar
• Ziegler SA, Lu L, da Rosa AP, Xiao SY, Tesh RB. An animal model for studying the pathogenesis of chikungunya virus infection. Am J Trop Med Hyg 2008; 79:133-9; PMID:18606777
   PubMed Web of Science ®Google Scholar
• Teo TH, Lum FK, Lee WWL, Ng LFP. Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology. Immunol Res 2012; 53:136-47; PMID:22418724; http://dx.doi.org/10.1007/s12026-012-8266-x
   PubMed Web of Science ®Google Scholar
• Oh HL, Akerstrom S, Shen S, Bereczky S, Karlberg H, Klingstrom J, Lal SK, Mirazimi A, Tan YJ. An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses. J Virol 2010; 84:8275-86; PMID:20519402; http://dx.doi.org/10.1128/JVI.02593-09
   PubMed Web of Science ®Google Scholar
• Ng OW, Keng CT, Leung CS, Peiris JS, Poon LL, Tan YJ. Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody. PLoS One 2014; 9:e102415; PMID:25019613; http://dx.doi.org/10.1371/journal.pone.0102415
   PubMed Web of Science ®Google Scholar
• Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, Sedlak D, Fremont DH, Chipman PR, Roehrig JT, et al. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol 2008; 15:312-7; PMID:18264114; http://dx.doi.org/10.1038/nsmb.1382
   PubMed Web of Science ®Google Scholar
• Stucky B. SeqTrace: a graphical tool for rapidly processing DNA sequencing chromatograms. J Biomol Tech 2012; 23:90-3; PMID:22942788; http://dx.doi.org/10.7171/jbt.12-2303-004
   PubMedGoogle Scholar
• Kelley L, Sternberg M. Protein structure prediction on the web: a case study using the Phyre server. Nat Protoc 2009; 4:363-71; PMID:19247286; http://dx.doi.org/10.1038/nprot.2009.2
   PubMed Web of Science ®Google Scholar
• Schrodinger L. The PyMOL molecular graphics system, version 1.3 r1. New York: Oxford University Press; 2010.
   Google Scholar
• Dell RB, Holleran S, Ramakrishnan R. Sample Size Determination. ILAR J 2002; 43:207-13; PMID:12391396; http://dx.doi.org/10.1093/ilar.43.4.207
   PubMedGoogle Scholar
• Bréhin AC, Rubrechtb L, Navarro-Sancheza ME, Maréchala V, Frenkiela MP, Lapaludb P, Launeb D, Sallc AA, Desprès P. Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein. Virol J 2008; 371:185-95; http://dx.doi.org/10.1016/j.virol.2007.09.028
   Web of Science ®Google Scholar